Edition:
United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

277.18USD
1:55pm EST
Change (% chg)

$-3.48 (-1.24%)
Prev Close
$280.66
Open
$280.35
Day's High
$282.72
Day's Low
$276.61
Volume
993,431
Avg. Vol
1,639,103
52-wk High
$333.65
52-wk Low
$223.02

Papadopoulos, Stelios 

Dr. Stelios B. Papadopoulos, Ph.D., is the Independent Chairman of the Board of Biogen Idec Inc., since June 2014. Dr. Papadopoulos is the Chairman of Exelixis, Inc., a drug discovery and development company that he co-founded in 1994. Previously, he was an investment banker with Cowen & Co., LLC, a financial services company, focusing on the biotechnology and pharmaceutical sectors, from 2000 until his retirement as Vice Chairman in August 2006. Prior to joining Cowen & Co., Dr. Papadopoulos served for 13 years as an investment banker at PaineWebber, Inc., a financial services company, where he was most recently Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. Dr. Papadopoulos is a member of the boards of directors of BG Medicine, Inc. and Regulus Therapeutics, Inc., both life sciences companies. During the past five years, Dr. Papadopoulos has also served as a director of Anadys Pharmaceuticals, Inc., a biopharmaceutical company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --